Figure 2
Effect (mean + SEM) of ovx on the expansion of ST-HSPCs and LT-HSPCs in T cell–replete and T cell–deficient mice. (A-C) Effects of ovx on the relative frequency of CD150−CD48− LSK cells (ST-HSPCs/MPPs) and CD150+CD48− LSK cells (LT-HSPCs) in WT, TCRβKO, and TCRβKO mice previously reconstituted with T cells. (Left) Representative flow cytometric dot plots from 1 mouse per group using the signalling lymphocyte activation molecule receptors CD150 and CD48. Parent population is Lin−Sca1+c-Kit+. The upper boxes delineate LT-HSPCs. The lower boxes delineate ST-HSPCs + MPPS. (Right) Mean + SEM for each group. Data are expressed as percentage of BMMCs. n = 10 mice per group. (D-I) Effect of ovx on peripheral blood cell expansion after primary competitive repopulation. The panels show the percentage of CD45.2+ myeloid cells (CD11b+), granulocytic cells (GR-1+), and B lineage cells (B220+) in the peripheral blood of lethally irradiated WT recipient mice that received CD45.2+ BM donor cells mixed in a 1:2 ratio with CD45.1+ competitor BM cells. CD45.2+ BM cells were obtained from WT, TCRβKO, and reconstituted TCRβKO mice subjected to sham operation or ovx 2 weeks earlier. CD45.1+ BM cells were obtained from intact WT mice. *P < .05 compared with the corresponding sham-operated group.

Effect (mean + SEM) of ovx on the expansion of ST-HSPCs and LT-HSPCs in T cell–replete and T cell–deficient mice. (A-C) Effects of ovx on the relative frequency of CD150CD48 LSK cells (ST-HSPCs/MPPs) and CD150+CD48 LSK cells (LT-HSPCs) in WT, TCRβKO, and TCRβKO mice previously reconstituted with T cells. (Left) Representative flow cytometric dot plots from 1 mouse per group using the signalling lymphocyte activation molecule receptors CD150 and CD48. Parent population is LinSca1+c-Kit+. The upper boxes delineate LT-HSPCs. The lower boxes delineate ST-HSPCs + MPPS. (Right) Mean + SEM for each group. Data are expressed as percentage of BMMCs. n = 10 mice per group. (D-I) Effect of ovx on peripheral blood cell expansion after primary competitive repopulation. The panels show the percentage of CD45.2+ myeloid cells (CD11b+), granulocytic cells (GR-1+), and B lineage cells (B220+) in the peripheral blood of lethally irradiated WT recipient mice that received CD45.2+ BM donor cells mixed in a 1:2 ratio with CD45.1+ competitor BM cells. CD45.2+ BM cells were obtained from WT, TCRβKO, and reconstituted TCRβKO mice subjected to sham operation or ovx 2 weeks earlier. CD45.1+ BM cells were obtained from intact WT mice. *P < .05 compared with the corresponding sham-operated group.

Close Modal

or Create an Account

Close Modal
Close Modal